dc.contributor.author |
Königsrainer, Alfred |
|
dc.date.accessioned |
2019-11-12T08:48:44Z |
|
dc.date.available |
2019-11-12T08:48:44Z |
|
dc.date.issued |
2018 |
|
dc.identifier.issn |
1365-2249 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/94598 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Wiley |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1111/cei.13093 |
de_DE |
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20190321153956_02841 |
|
utue.publikation.seiten |
233-241 |
de_DE |
utue.personen.roh |
Bigenzahn, S. |
|
utue.personen.roh |
Juergens, B. |
|
utue.personen.roh |
Mahr, B. |
|
utue.personen.roh |
Pratschke, J. |
|
utue.personen.roh |
Koenigsrainer, A. |
|
utue.personen.roh |
Becker, T. |
|
utue.personen.roh |
Fuchs, D. |
|
utue.personen.roh |
Brandacher, G. |
|
utue.personen.roh |
Kainz, A. |
|
utue.personen.roh |
Muehlbacher, F. |
|
utue.personen.roh |
Wekerle, T. |
|
dcterms.isPartOf.ZSTitelID |
Clinical and Experimental Immunology |
de_DE |
dcterms.isPartOf.ZS-Issue |
2 |
de_DE |
dcterms.isPartOf.ZS-Volume |
192 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |